Tectonic Therapeutic (TECX) News Today $22.58 -1.98 (-8.06%) Closing price 04:00 PM EasternExtended Trading$22.59 +0.01 (+0.04%) As of 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TECX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Soleus Capital Management L.P. Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX)Soleus Capital Management L.P. purchased a new position in Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 31,841 shares of the company's stock, valued at approximaMay 21 at 8:13 AM | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Given Average Rating of "Buy" by AnalystsMay 19 at 2:05 AM | americanbankingnews.comTectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $85.00 at MizuhoMay 18 at 1:55 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and Amgen (AMGN)May 17, 2025 | theglobeandmail.comTectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in ...May 17, 2025 | gurufocus.comTectonic Therapeutic Reports Positive Phase 1b Results for TX45 in Group 2 Pulmonary Hypertension Patients with Heart Failure and Preserved Ejection FractionMay 17, 2025 | quiverquant.comTectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025May 17, 2025 | globenewswire.comParadigm Biocapital Advisors LP Takes $22.40 Million Position in Tectonic Therapeutic (NASDAQ:TECX)Paradigm Biocapital Advisors LP purchased a new position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 485,105 shares of the company's stock, valued at approMay 16, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Receives Consensus Recommendation of "Buy" from AnalystsTectonic Therapeutic (NASDAQ:TECX - Get Free Report) has earned a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy ratinMay 16, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Expectations By $0.17 EPSTectonic Therapeutic (NASDAQ:TECX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.93) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.10) by $0.17.May 12, 2025 | marketbeat.comFarallon Capital Management LLC Boosts Holdings in Tectonic Therapeutic (NASDAQ:TECX)Farallon Capital Management LLC raised its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 37.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 713,050 shares of the company's stockMay 11, 2025 | marketbeat.comBalyasny Asset Management L.P. Has $11.40 Million Stock Holdings in Tectonic Therapeutic (NASDAQ:TECX)Balyasny Asset Management L.P. increased its position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 36.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 247,000 shares of the company's stock after buying an additionaMay 11, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Purchased by Barclays PLCBarclays PLC boosted its position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 1,008.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,974 shares of the company's stock after buyingMay 9, 2025 | marketbeat.comTectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business HighlightsMay 8, 2025 | globenewswire.comInsider Stock Buying Reaches US$62.6m On Tectonic TherapeuticMay 5, 2025 | finance.yahoo.comTectonic Therapeutic (NASDAQ:TECX) is 5AM Venture Management LLC's 4th Largest Position5AM Venture Management LLC decreased its stake in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 7.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 596,660 shares of the company's stock after selling 49,864 shares during the quarter.May 4, 2025 | marketbeat.com683 Capital Management LLC Invests $648,000 in Tectonic Therapeutic (NASDAQ:TECX)683 Capital Management LLC bought a new stake in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 14,027 shares of the company's stock, valued at approxiMay 4, 2025 | marketbeat.comAcuta Capital Partners LLC Increases Position in Tectonic Therapeutic (NASDAQ:TECX)Acuta Capital Partners LLC lifted its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 140.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 33,008 shares of the company's stock after buying an additional 19,308 sharesMay 4, 2025 | marketbeat.comSusquehanna International Group LLP Purchases 103,698 Shares of Tectonic Therapeutic (NASDAQ:TECX)Susquehanna International Group LLP raised its holdings in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 165.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 166,452 shares of the compaMay 4, 2025 | marketbeat.comTectonic Therapeutic (TECX) to Release Earnings on ThursdayTectonic Therapeutic (NASDAQ:TECX) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-tectonic-therapeutic-stock/)May 3, 2025 | marketbeat.comTectonic Therapeutic (TECX): Potential and Challenges in Drug DevelopmentMay 2, 2025 | gurufocus.comBoothbay Fund Management LLC Lowers Stake in Tectonic Therapeutic (NASDAQ:TECX)Boothbay Fund Management LLC lowered its stake in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 45.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,307 shares of the company's stock after selling 34,April 30, 2025 | marketbeat.comArtia Global Partners LP Makes New $769,000 Investment in Tectonic Therapeutic (NASDAQ:TECX)Artia Global Partners LP acquired a new stake in Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 16,650 shares of the company's stock, valued at approximately $769,000April 29, 2025 | marketbeat.comInvesco Ltd. Purchases New Stake in Tectonic Therapeutic (NASDAQ:TECX)Invesco Ltd. acquired a new position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 128,178 shares of the company's stock, valued at approximately $5,918,000. Invesco Ltd. owned approximaApril 28, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at MizuhoMizuho started coverage on Tectonic Therapeutic in a research note on Monday. They issued an "outperform" rating and a $51.00 price target on the stock.April 23, 2025 | marketbeat.comTectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEFApril 23, 2025 | seekingalpha.comTectonic Therapeutic (NASDAQ:TECX) Short Interest UpdateTectonic Therapeutic (NASDAQ:TECX - Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,100,000 shares, an increase of 24.7% from the March 15th total of 882,400 shares. Based on an average daily volume of 350,300 shares, the short-interest ratio is presently 3.1 days. Approximately 10.3% of the company's shares are sold short.April 22, 2025 | marketbeat.comTectonic Therapeutic initiated with an Outperform at MizuhoApril 21, 2025 | markets.businessinsider.comMizuho Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform RecommendationApril 21, 2025 | msn.comTectonic Therapeutic (NASDAQ:TECX) Receives Average Rating of "Buy" from BrokeragesTectonic Therapeutic (NASDAQ:TECX - Get Free Report) has been given an average recommendation of "Buy" by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation and one has issued a strong buy recoApril 21, 2025 | marketbeat.comTectonic Therapeutic (TECX) Receives Outperform Rating from Mizuho | TECX Stock NewsApril 21, 2025 | gurufocus.comVanguard Group Inc. Has $16.67 Million Position in Tectonic Therapeutic (NASDAQ:TECX)Vanguard Group Inc. cut its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 18.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 361,048 shares of the company's stock after selling 81,766 shares duriApril 19, 2025 | marketbeat.comTectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025April 15, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $54,877.68 in StockApril 12, 2025 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $1,496,250.00 in StockApril 10, 2025 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Shares Sold by ADAR1 Capital Management LLCADAR1 Capital Management LLC trimmed its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 53.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 58,708 shares of the company's stock after selling 68,451 sApril 9, 2025 | marketbeat.comTectonic Therapeutic files to sell 3.69M shares of common stock for holdersMarch 27, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Given Consensus Recommendation of "Buy" by BrokeragesShares of Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) have earned an average recommendation of "Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating and one has assigned a strong buMarch 25, 2025 | marketbeat.comWells Fargo & Company Has Lowered Expectations for Tectonic Therapeutic (NASDAQ:TECX) Stock PriceWells Fargo & Company cut their price objective on Tectonic Therapeutic from $112.00 to $101.00 and set an "overweight" rating for the company in a report on Friday.March 22, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Releases Quarterly Earnings Results, Beats Expectations By $0.08 EPSTectonic Therapeutic (NASDAQ:TECX - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.84) EPS for the quarter, topping analysts' consensus estimates of ($0.92) by $0.08.March 21, 2025 | marketbeat.comTectonic Therapeutic Inc (TECX) Reports Q4 2024 Net Loss of $12. ...March 20, 2025 | gurufocus.comTectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent ...March 20, 2025 | gurufocus.comTectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsMarch 20, 2025 | globenewswire.comTectonic Therapeutic (NASDAQ:TECX) Stake Trimmed by Atlas Venture Life Science Advisors LLCAtlas Venture Life Science Advisors LLC cut its position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 79.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 78,447 shares of the company'March 7, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Sees Significant Decrease in Short InterestTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 888,500 shares, a decrease of 16.2% from the January 31st total of 1,060,000 shares. Based on an average trading volume of 284,700 shares, the short-interest ratio is currently 3.1 days. Currently, 10.3% of the shares of the company are sold short.March 6, 2025 | marketbeat.comTectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on ThursdayTectonic Therapeutic (NASDAQ:TECX) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Given Consensus Rating of "Buy" by BrokeragesTectonic Therapeutic (NASDAQ:TECX - Get Free Report) has been given an average rating of "Buy" by the six brokerages that are currently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendaFebruary 28, 2025 | marketbeat.comTectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying RecentlyFebruary 22, 2025 | msn.comTectonic Therapeutic to Participate in March Investor ConferencesFebruary 20, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short InterestTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,060,000 shares, an increase of 60.3% from the January 15th total of 661,100 shares. Based on an average daily volume of 260,900 shares, the short-interest ratio is currently 4.1 days. Currently, 13.8% of the shares of the company are short sold.February 13, 2025 | marketbeat.com Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address TECX Media Mentions By Week TECX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECX News Sentiment▼1.030.65▲Average Medical News Sentiment TECX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECX Articles This Week▼103▲TECX Articles Average Week Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Edgewise Therapeutics News Today Immunocore News Today Travere Therapeutics News Today Mesoblast News Today Structure Therapeutics News Today Janux Therapeutics News Today Evotec News Today ARS Pharmaceuticals News Today Adaptive Biotechnologies News Today Vera Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TECX Stock Free TECX Stock Alerts